Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
0.38
Nov. 18, 2025 16:00:00- Change 0.0094 (2.53096%)
- Volume 1,377,233
- Today's Open 0.3648
- Previous Close 0.3714
- Today's High 0.3835
- Today's Low 0.35
- 52 Week High 4.3
- 52 Week Low 0.281